MicroTrace BioAI Overview

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 3

MicroTrace BioAI General Information

Description

Developer of fragment-native artificial intelligence models designed to decode molecular signals from cell-free DNA. The company develops multimodal AI models that learn from DNA, RNA, and protein signals on individual fragments, enabling clinical researchers to identify patterns relevant to cancer and improve diagnostic decision-making.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • San Jose, CA
  • United States
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • San Jose, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroTrace BioAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Oct-2026 Completed Product Development
To view MicroTrace BioAI’s complete valuation and funding history, request access »

MicroTrace BioAI Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Betafund Ai Accelerator/Incubator Minority
Boutique Venture Partners Venture Capital Minority
xNova VC Venture Capital Minority
To view MicroTrace BioAI’s complete investors history, request access »

MicroTrace BioAI FAQs

  • Where is MicroTrace BioAI headquartered?

    MicroTrace BioAI is headquartered in San Jose, CA.

  • What industry is MicroTrace BioAI in?

    MicroTrace BioAI’s primary industry is Other Healthcare Technology Systems.

  • Is MicroTrace BioAI a private or public company?

    MicroTrace BioAI is a Private company.

  • What is MicroTrace BioAI’s current revenue?

    The current revenue for MicroTrace BioAI is .

  • Who are MicroTrace BioAI’s investors?

    Betafund Ai, Boutique Venture Partners, and xNova VC have invested in MicroTrace BioAI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process